NLS Pharmaceutics (NLSP) has released an update.
NLS Pharmaceutics Ltd. has announced its ordinary shareholders’ meeting scheduled for June 27, 2024, where key proposals including the election of board members, approval of financial statements, and executive compensation will be voted upon. Shareholders registered by June 5, 2024, are eligible to vote, with options to participate in person or appoint a proxy. The meeting will address the company’s financial results and set compensation for board members and executive management for the upcoming year.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
